关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Hainan's current normal trading varieties

Release time:

2023-07-24

Product Name Specifications Packaging
Ambroxol Hydrochloride Capsules 30mg 30mg*12 capsules/box
Ambroxol Hydrochloride Capsules 30mg 30mg*24 capsules/box
Ambroxol Hydrochloride Capsules 30mg 30mg*36 capsules/box
Guipi Capsule 0.3g 0.3g*24 tablets/box
Guipi Capsule 0.3g 0.3g*36 capsules/box
Fenofibrate Capsules 0.2g 0.2g×20 tablets/box
Clindamycin hydrochloride for injection 0.6g 0.6g×1 bottle/bottle
Clindamycin hydrochloride for injection 0.3g 0.3g×1 bottle/bottle
Clindamycin hydrochloride for injection 0.15g 0.15g×1 bottle/bottle
Azithromycin for Injection 0.5g (500,000 units) 0.5g (500,000 units)×1 piece/piece
Cefoxitin Sodium for Injection 0.5g 0.5g×1 bottle/bottle
Cefoxitin Sodium for Injection 1.0g 1.0g×1 bottle/bottle
Lysine for Injection 0.9g (based on lysine) 0.9g (based on lysine) ×10 bottles/box
Clindamycin Phosphate Injection 2ml:0.3g 2ml:0.3g×10 bottles/box
Clindamycin Phosphate Injection 4ml:0.6g 4ml:0.6g×10 bottles/box
Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs